Indian Journal of Pharmacology Home 

DRUG WATCH
[View FULLTEXT] [Download PDF]
Year : 2014  |  Volume : 46  |  Issue : 3  |  Page : 339--340

Spontaneous rectus sheath hematoma during rivaroxaban therapy

Ibrahim Kocayigit1, Yusuf Can2, Salih Sahinkus2, Ercan Aydin3, Mehmet Bulent Vatan2, Harun Kilic2, Huseyin Gunduz2 
1 Department of Cardiology, Yenikent State Hospital, Turkey
2 Department of Cardiology, Faculty of Medicine, Sakarya University, Sakarya, Turkey
3 Department of Cardiology, Vakfikebir State Hospital, Trabzon, Turkey

Correspondence Address:
Ibrahim Kocayigit
Department of Cardiology, Yenikent State Hospital
Turkey

Rivaroxaban is an oral anticoagulant agent that directly inhibits Factor Xa and interrupts both the intrinsic and extrinsic pathway of the coagulation cascade and is currently indicated for use in patients for atrial fibrillation and prophylaxis of deep venous thrombosis. The present case reports of spontaneous rectus sheath hematoma during rivaroxaban therapy for atrial fibrillation in a 75-year-old woman.


How to cite this article:
Kocayigit I, Can Y, Sahinkus S, Aydin E, Vatan MB, Kilic H, Gunduz H. Spontaneous rectus sheath hematoma during rivaroxaban therapy.Indian J Pharmacol 2014;46:339-340


How to cite this URL:
Kocayigit I, Can Y, Sahinkus S, Aydin E, Vatan MB, Kilic H, Gunduz H. Spontaneous rectus sheath hematoma during rivaroxaban therapy. Indian J Pharmacol [serial online] 2014 [cited 2021 Sep 20 ];46:339-340
Available from: https://www.ijp-online.com/article.asp?issn=0253-7613;year=2014;volume=46;issue=3;spage=339;epage=340;aulast=Kocayigit;type=0